CEA Antibody (RC66), mAb, Mouse

CEA (RC66), mAb, Mouse

Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease.
V06201
¥20,887.00

Ask us a question
Description

Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease.
Synonyms

CEA Antibody (RC66), mAb, Mouse

Note

GenScript can customize this product per customer's request including product size, buffer components, etc.

Overview
Subclass IgG1
Host Species Mouse
Conjugation Unconjugated
Antigen Species Human

Properties
Production Cultured in vitro under conditions free from animal-derived components
Purification Protein A/G affinity column
Formulation 1) PBS, pH 7.4, containing 0.03% Proclin 300
2) 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 *
*: For new batch since 09/01/2018, please refer to COA.
Concentration ≥2mg/ml
Clone ID RC66
Recommended pairs Sandwich immunoassay (Capture-Detection):
RC66–RC67
Storage For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.

Applications
ELISA

Background
Target Background Carcinoembroyonic antigen (CEA) is a glycoprotein, produced during the embryonic and fetal period. The high concentration of CEA in blood are observed in many patients with cancer of the lung, liver, pancreas, breast, colon and prostate. The elevated CEA levels are related to the stage of the disease.